HOGENHUIS WLADIMIR (Chief Operating Officer) reported 1 transaction at ULTRAGENYX PHARMACEUTICAL INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/7/2019ACC: 0001209191-19-052722
Officer· Chief Operating Officer
Since Sep 2018
-1.30K
Net shares
Net seller
$57.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.30K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.30K
Price / share
$44.52
Trade value
$57.74K
% of position
6.5%
10/4/2019
20K→18.70K
Total
Net shares
−1.30K
Net value
-$57.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/4/2019 | F · Tax Withholding | −1.30K | $44.52 | $57.74K | 6.5% | 20K | 18.70K |
| Total | −1.30K | -$57.74K | ||||||
Derivative Transactions0
No derivative transactions reported